Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
65.06
+1.50 (+2.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gilead Sciences
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
46
47
Next >
2 Top Biotech Stocks to Buy in June
June 09, 2023
Both companies have solid therapy franchises and continue to expand their horizons.
Via
The Motley Fool
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
June 08, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making...
Via
FinancialNewsMedia
3 Biotech Stocks That Could Skyrocket in the Next 12 Months
June 07, 2023
These promising biotech stocks are risky but offer tremendous upside generating stellar long-term returns in the upcoming 12 months.
Via
InvestorPlace
AbTherx Announces License Agreement with Gilead
June 07, 2023
Via
ACCESSWIRE
Kite’s Tecartus® CAR T-cell Therapy Demonstrates 78% Complete Response Rate and 90% Overall Response Rate in Largest Real-World Evidence Analysis for Relapsed/Refractory Mantle Cell Lymphoma
June 06, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
June 06, 2023
Via
Benzinga
Mount Gilead, NC Author Publishes Children's Book
May 17, 2023
Take In The Beauty Of Nature And Quiet The Outside World.
Via
PR Leap
Trodelvy® Continues to Show Durable Overall Survival Advantage in Pre-Treated HR+/HER2- Metastatic Breast Cancer
June 05, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Kite’s Yescarta® CAR T-cell Therapy Demonstrates Significantly Longer Overall Survival Versus Standard of Care as Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma
June 05, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
June 05, 2023
ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference.
Via
Investor's Business Daily
A Look Into Gilead Sciences' Debt
May 16, 2023
Via
Benzinga
Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer
June 05, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NASDAQ:RAIN),(NASDAQ:CNSP),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study
June 03, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
3 Dividend Stocks You Can Buy Without Any Hesitation
June 03, 2023
The choices are easy with these stocks.
Via
The Motley Fool
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
June 02, 2023
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.
Via
InvestorPlace
Gilead and Kite Oncology Demonstrate Growing Hematology Pipeline and Strength of Leading Cell Therapy Portfolio at EHA
June 01, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Stocks Going Ex-Dividend In June 2023
May 27, 2023
The following is a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as...
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
May 26, 2023
Via
Benzinga
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting’s Oral Presentations
May 26, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:IMGN),(NASDAQ:DAWN),(NASDAQ:LEGN) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class
May 26, 2023
Roche tested its treatment in patients with liver cancer and found "meaningful" results.
Via
Investor's Business Daily
CHMP Adopts Positive Opinion to Extend the Use of Veklury® (Remdesivir) to Treat COVID-19 in People With Severe Renal Impairment, Including Those on Dialysis
May 26, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences to Present at Upcoming Investor Conference
May 25, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark
May 25, 2023
On Thursday, Gilead Sciences stock had its Relative Strength (RS) Rating upgraded to 81, up from 78 a day earlier.
Via
Investor's Business Daily
3 Relatively Safe Stocks to Buy if a Recession Is on the Way
May 20, 2023
If the economy falters, these stocks should hold up better than most.
Via
The Motley Fool
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
May 18, 2023
Vertex Pharmaceuticals hits record high on strong earnings, FDA approval for cystic fibrosis medication for infants. Analysts recently boosted price targets.
Via
MarketBeat
Exposures
Product Safety
3 Analyst Upgrades That Smart Investors Won’t Ignore
May 17, 2023
In many cases, analyst upgrades can point investors to opportunities like the ones in the stocks on this list.
Via
InvestorPlace
Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023
May 17, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Appoints Cindy Perettie Executive Vice President of Kite
May 16, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
GDC Stock Alert: Why Is GD Culture Group Up 106% Today?
May 16, 2023
GD Culture (GDC) stock is rocketing higher on Tuesday with investors reacting to the company's earnings report for Q1 2023.
Via
InvestorPlace
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
46
47
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.